应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AKBA Akebia Therapeutics, Inc.
盘前交易 07-24 07:52:21 EDT
4.01
+0.16
+4.16%
最高
4.02
最低
3.85
成交量
278.08万
今开
3.89
昨收
3.85
日振幅
4.42%
总市值
10.53亿
流通市值
10.32亿
总股本
2.63亿
成交额
1,101万
换手率
1.08%
流通股本
2.57亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Akebia Therapeutics, Inc.盘中异动 快速下跌5.19%报3.63美元
市场透视 · 06-10
Akebia Therapeutics, Inc.盘中异动 快速下跌5.19%报3.63美元
Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.00%
市场透视 · 05-20
Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.00%
Akebia Therapeutics, Inc.盘中异动 股价大涨5.03%报2.74美元
市场透视 · 05-19
Akebia Therapeutics, Inc.盘中异动 股价大涨5.03%报2.74美元
Akebia Therapeutics, Inc.2025财年第一财季实现净利润6.11百万美元,同比增加133.96%
市场透视 · 05-17
Akebia Therapeutics, Inc.2025财年第一财季实现净利润6.11百万美元,同比增加133.96%
Akebia Therapeutics, Inc.盘中异动 大幅下挫5.10%
市场透视 · 05-12
Akebia Therapeutics, Inc.盘中异动 大幅下挫5.10%
Akebia Therapeutics, Inc.股价上涨11.38% 市值涨8162.76万美元
市场透视 · 05-08
Akebia Therapeutics, Inc.股价上涨11.38% 市值涨8162.76万美元
Akebia Therapeutics, Inc.盘中异动 临近收盘急速上涨5.17%
市场透视 · 05-07
Akebia Therapeutics, Inc.盘中异动 临近收盘急速上涨5.17%
Akebia Therapeutics获Leerink Partners首次覆盖,给予优于大市评级, 目标价7.00美元。
金融界 · 04-28
Akebia Therapeutics获Leerink Partners首次覆盖,给予优于大市评级, 目标价7.00美元。
Akebia Therapeutics, Inc.盘中异动 股价大涨5.04%
市场透视 · 04-25
Akebia Therapeutics, Inc.盘中异动 股价大涨5.04%
Akebia Therapeutics, Inc.盘中异动 大幅拉升5.14%
市场透视 · 04-23
Akebia Therapeutics, Inc.盘中异动 大幅拉升5.14%
Akebia Therapeutics, Inc.盘中异动 急速拉升5.26%
市场透视 · 04-17
Akebia Therapeutics, Inc.盘中异动 急速拉升5.26%
Akebia Therapeutics, Inc.盘中异动 股价大涨5.00%
市场透视 · 02-27
Akebia Therapeutics, Inc.盘中异动 股价大涨5.00%
Akebia Therapeutics, Inc.盘中异动 下午盘股价大跌5.50%
市场透视 · 02-21
Akebia Therapeutics, Inc.盘中异动 下午盘股价大跌5.50%
Akebia Therapeutics, Inc.盘中异动 早盘股价大跌5.09%
市场透视 · 02-03
Akebia Therapeutics, Inc.盘中异动 早盘股价大跌5.09%
Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.07%
市场透视 · 01-21
Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.07%
Akebia Therapeutics, Inc.盘中异动 大幅拉升5.44%报2.04美元
市场透视 · 01-17
Akebia Therapeutics, Inc.盘中异动 大幅拉升5.44%报2.04美元
Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.25%
市场透视 · 01-15
Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.25%
HC Wainwright & Co.:重申Akebia Therapeutics(AKBA.US)评级,由买入调整至买入评级, 目标价由7.50美元调整至7.50美元。
金融界 · 01-14
HC Wainwright & Co.:重申Akebia Therapeutics(AKBA.US)评级,由买入调整至买入评级, 目标价由7.50美元调整至7.50美元。
Akebia Therapeutics, Inc.盘中异动 急速上涨5.14%报1.84美元
市场透视 · 01-13
Akebia Therapeutics, Inc.盘中异动 急速上涨5.14%报1.84美元
Akebia Therapeutics, Inc.盘中异动 临近收盘股价大跌5.13%
市场透视 · 2024-12-30
Akebia Therapeutics, Inc.盘中异动 临近收盘股价大跌5.13%
加载更多
公司概况
公司名称:
Akebia Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Akebia Therapeutics, Inc.依法于2007年2月27日在特拉华州成立。该公司是一家致力于:基于缺氧诱导因子的新型生物性专有疗法的研发,肾脏疾病患者所需产品商业化应用的生物制药公司。HIF是人体内红细胞生成和潜在贫血治疗新机制的主要调节器。Akebia的候选主导产品AKB-6548作为一种每日一次的口服产品,已经成功完成2a期概念验证。研究表明AKB-6548可以在不需要透析的情况下安全有效地提高继发性贫血和慢性肾病患者的血红蛋白水平。
发行价格:
--
{"stockData":{"symbol":"AKBA","market":"US","secType":"STK","nameCN":"Akebia Therapeutics, Inc.","latestPrice":4.01,"timestamp":1753300800000,"preClose":3.85,"halted":0,"volume":2780783,"delay":0,"floatShares":257291800,"shares":262635836,"eps":-0.207304,"marketStatus":"盘前交易","change":0.16,"latestTime":"07-24 07:52:21 EDT","open":3.89,"high":4.02,"low":3.85,"amount":11006051.3029595,"amplitude":0.044156,"askPrice":4.02,"askSize":697,"bidPrice":3.97,"bidSize":803,"shortable":3,"etf":0,"ttmEps":-0.207304,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753363800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1395288000000,"exchange":"NASDAQ","adjPreClose":4.01,"postHourTrading":{"tag":"盘后","latestPrice":4.0193,"preClose":4.01,"latestTime":"19:32 EDT","volume":39988,"amount":160121.0635,"timestamp":1753313538130},"volumeRatio":1.102142802521503,"impliedVol":1.8387,"impliedVolPercentile":0.9598},"requestUrl":"/m/hq/s/AKBA","defaultTab":"news","newsList":[{"id":"2542170603","title":"Akebia Therapeutics, Inc.盘中异动 快速下跌5.19%报3.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542170603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542170603?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:31","pubTimestamp":1749562308,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时31分,Akebia Therapeutics, Inc.股票出现异动,股价急速跳水5.19%。截至发稿,该股报3.63美元/股,成交量70.6353万股,换手率0.27%,振幅4.31%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.43%。其相关个股中,Gelteq Limited、正业生物、博美集团涨幅较大,Gelteq Limited、Incannex Healthcare Inc.、Shuttle Pharmaceuticals Holdings, Inc.较为活跃,换手率分别为242.18%、104.94%、1.79%,振幅较大的相关个股有Gelteq Limited、Aytu Biopharma, Inc.、Phibro Animal Health Corporation,振幅分别为8.20%、7.58%、6.33%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213149a70238e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610213149a70238e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","AKBA"],"gpt_icon":0},{"id":"2536164901","title":"Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536164901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536164901?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:15","pubTimestamp":1747754147,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时15分,Akebia Therapeutics, Inc.股票出现波动,股价急速上涨5.00%。截至发稿,该股报2.94美元/股,成交量183.278万股,换手率0.70%,振幅5.00%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体跌幅为0.05%。其相关个股中,Incannex Healthcare Inc.、脑再生科技、Scilex Holding Company涨幅较大,Petros Pharmaceuticals, Inc.、Incannex Healthcare Inc.、Shuttle Pharmaceuticals Holdings, Inc.较为活跃,换手率分别为346.43%、285.27%、8.83%,振幅较大的相关个股有脑再生科技、Incannex Healthcare Inc.、正业生物,振幅分别为26.82%、20.01%、16.11%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520231548aa2c9432&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520231548aa2c9432&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2536636056","title":"Akebia Therapeutics, Inc.盘中异动 股价大涨5.03%报2.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536636056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536636056?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:14","pubTimestamp":1747671274,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日00时14分,Akebia Therapeutics, Inc.股票出现波动,股价急速拉升5.03%。截至发稿,该股报2.74美元/股,成交量167.626万股,换手率0.64%,振幅5.94%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.24%。其相关个股中,苏轩堂、正业生物、Quantum Biopharma Ltd.涨幅较大,Petros Pharmaceuticals, Inc.、Incannex Healthcare Inc.、苏轩堂较为活跃,换手率分别为224.09%、133.83%、53.24%,振幅较大的相关个股有苏轩堂、脑再生科技、正业生物,振幅分别为27.51%、27.46%、25.95%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520001434a6e4f3db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520001434a6e4f3db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4007","BK4139","AKBA"],"gpt_icon":0},{"id":"2536582502","title":"Akebia Therapeutics, Inc.2025财年第一财季实现净利润6.11百万美元,同比增加133.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536582502","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536582502?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497623,"startTime":"0","endTime":"0","summary":"5月18日,Akebia Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为6.11百万美元,同比增加133.96%;其中营业收入为57.34百万美元,同比增加75.84%,每股基本收益为0.03美元。从资产负债表来看,Akebia Therapeutics, Inc.总负债2.86亿美元,其中短期债务24.13百万美元,资产负债比为1.09,流动比率为0.03。机构评级:截至2025年5月18日,当前有5家机构对Akebia Therapeutics, Inc.目标价做出预测,其中目标均价为7.30美元,其中最低目标价为6.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000115a6e2d7ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000115a6e2d7ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA"],"gpt_icon":0},{"id":"2534620834","title":"Akebia Therapeutics, Inc.盘中异动 大幅下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534620834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534620834?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:38","pubTimestamp":1747057123,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时38分,Akebia Therapeutics, Inc.股票出现异动,股价快速下挫5.10%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.64%。其相关个股中,脑再生科技、Medicus Pharma Ltd.、坎伯兰药业涨幅较大,Shuttle Pharmaceuticals Holdings, Inc.、Petros Pharmaceuticals, Inc.、Incannex Healthcare Inc.较为活跃,换手率分别为188.48%、76.95%、6.29%,振幅较大的相关个股有脑再生科技、Incannex Healthcare Inc.、Medicus Pharma Ltd.,振幅分别为13.54%、12.78%、10.89%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213843aa2c8b2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213843aa2c8b2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","AKBA","LENZ","BK4007"],"gpt_icon":0},{"id":"2533913105","title":"Akebia Therapeutics, Inc.股价上涨11.38% 市值涨8162.76万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533913105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533913105?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:32","pubTimestamp":1746711128,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时32分,Akebia Therapeutics, Inc.股票出现波动,股价快速上涨11.38%。截至发稿,该股报2.74美元/股,成交量149.03万股,换手率0.57%,振幅5.28%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体跌幅为1.10%。其相关个股中,脑再生科技、Alvotech、Emergent Biosolutions Inc.涨幅较大,Painreform Ltd.、Mira Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.较为活跃,换手率分别为134.58%、37.94%、28.10%,振幅较大的相关个股有脑再生科技、Evolus, Inc. Common Stock、Akebia Therapeutics, Inc.,振幅分别为17.75%、5.87%、5.28%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213208a6d7c3ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213208a6d7c3ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2533650679","title":"Akebia Therapeutics, Inc.盘中异动 临近收盘急速上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533650679?lang=zh_cn&edition=full","pubTime":"2025-05-08 03:44","pubTimestamp":1746647061,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日03时44分,Akebia Therapeutics, Inc.股票出现异动,股价急速上涨5.17%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.05%。其相关个股中,Scilex Holding Company C/Wts 10/11/2027 、Elanco Animal Health Incorporated、脑再生科技涨幅较大,Petros Pharmaceuticals, Inc.、大自然药业、Quantum Biopharma Ltd.较为活跃,换手率分别为368.68%、39.05%、36.48%,振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、脑再生科技、正业生物,振幅分别为44.87%、37.52%、27.57%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508034421a6d6b488&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508034421a6d6b488&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2530240273","title":"Akebia Therapeutics获Leerink Partners首次覆盖,给予优于大市评级, 目标价7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530240273","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530240273?lang=zh_cn&edition=full","pubTime":"2025-04-28 20:41","pubTimestamp":1745844090,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics(AKBA.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042820444294e5e33e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042820444294e5e33e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA"],"gpt_icon":0},{"id":"2530534165","title":"Akebia Therapeutics, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530534165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530534165?lang=zh_cn&edition=full","pubTime":"2025-04-26 02:03","pubTimestamp":1745604188,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日02时03分,Akebia Therapeutics, Inc.股票出现波动,股价大幅上涨5.04%。截至发稿,该股报2.40美元/股,成交量122.121万股,换手率0.47%,振幅5.70%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.98%。其相关个股中,苏轩堂、惠普森医药、Mira Pharmaceuticals, Inc.涨幅较大,苏轩堂、Sonoma Pharmaceuticals, Inc.、大自然药业较为活跃,换手率分别为260.69%、63.66%、63.25%,振幅较大的相关个股有苏轩堂、Sunshine Biopharma Inc C/Wts 、Scilex Holding Company C/Wts 10/11/2027 ,振幅分别为94.30%、36.32%、31.26%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042602030894e2cab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042602030894e2cab3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2529929682","title":"Akebia Therapeutics, Inc.盘中异动 大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529929682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529929682?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415061,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分,Akebia Therapeutics, Inc.股票出现波动,股价快速上涨5.14%。截至发稿,该股报2.25美元/股,成交量2.4786万股,换手率0.01%,振幅0.00%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.00%。其相关个股中,Sonoma Pharmaceuticals, Inc.、Sunshine Biopharma Inc.、Shuttle Pharmaceuticals Holdings, Inc.涨幅较大,Sonoma Pharmaceuticals, Inc.、Mira Pharmaceuticals, Inc.、苏轩堂较为活跃,换手率分别为2260.50%、18.00%、10.00%,振幅较大的相关个股有Emergent Biosolutions Inc.、Shuttle Pharmaceuticals Holdings, Inc.、Sonoma Pharmaceuticals, Inc.,振幅分别为6.57%、5.73%、3.86%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321310194dfa6b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321310194dfa6b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA","BK4139","BK4007"],"gpt_icon":0},{"id":"2528749868","title":"Akebia Therapeutics, Inc.盘中异动 急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528749868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528749868?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:47","pubTimestamp":1744897677,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时47分,Akebia Therapeutics, Inc.股票出现波动,股价大幅上涨5.26%。截至发稿,该股报2.00美元/股,成交量41.2064万股,换手率0.16%,振幅4.74%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为8.77%。其相关个股中,Sunshine Biopharma Inc C/Wts 、礼来、苏轩堂涨幅较大,Redhill Biopharma Ltd、大自然药业、Mira Pharmaceuticals, Inc.较为活跃,换手率分别为30.70%、9.20%、3.73%,振幅较大的相关个股有苏轩堂、Redhill Biopharma Ltd、Canopy Growth Corporation,振幅分别为36.40%、28.49%、13.56%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041721475894d8d5e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041721475894d8d5e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA","BK4007"],"gpt_icon":0},{"id":"2514038944","title":"Akebia Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514038944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514038944?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:12","pubTimestamp":1740669173,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时12分,Akebia Therapeutics, Inc.股票出现波动,股价急速拉升5.00%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.72%。其相关个股中,Ironwood医药、Optinose, Inc.、基立福涨幅较大,Petros Pharmaceuticals, Inc.、苏轩堂、Quantum Biopharma Ltd.较为活跃,换手率分别为23.43%、12.19%、6.32%,振幅较大的相关个股有Petros Pharmaceuticals, Inc.、Cyclo Therapeutics Inc C/Wts 11/12/2025、Quantum Biopharma Ltd.,振幅分别为23.11%、20.58%、20.28%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231253abdf79aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231253abdf79aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AKBA"],"gpt_icon":0},{"id":"2513169202","title":"Akebia Therapeutics, Inc.盘中异动 下午盘股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513169202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513169202?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:26","pubTimestamp":1740162384,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时26分,Akebia Therapeutics, Inc.股票出现波动,股价大幅跳水5.50%。截至发稿,该股报1.81美元/股,成交量175.929万股,换手率0.81%,振幅7.33%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为1.31%。其相关个股中,Sunshine Biopharma Inc C/Wts 、大自然药业、Therapeuticsmd, Inc.涨幅较大,大自然药业、Therapeuticsmd, Inc.、Petros Pharmaceuticals, Inc.较为活跃,换手率分别为4252.01%、105.48%、34.98%,振幅较大的相关个股有大自然药业、Sunshine Biopharma Inc C/Wts 、Therapeuticsmd, Inc.,振幅分别为118.46%、63.34%、62.87%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222022624962baffc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222022624962baffc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA"],"gpt_icon":0},{"id":"2508149384","title":"Akebia Therapeutics, Inc.盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508149384?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分,Akebia Therapeutics, Inc.股票出现波动,股价大幅跳水5.09%。截至发稿,该股报2.13美元/股,成交量11.9169万股,换手率0.05%,振幅1.34%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体跌幅为0.30%。其相关个股中,脑再生科技、大自然药业、Incannex Healthcare Inc.涨幅较大,Inmed Pharmaceuticals Inc.、Painreform Ltd.、苏轩堂较为活跃,换手率分别为28.80%、4.13%、1.59%,振幅较大的相关个股有Ironwood医药、苏轩堂、Canopy Growth Corporation,振幅分别为5.13%、4.88%、4.52%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223233abc106f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223233abc106f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","BK4139","LENZ"],"gpt_icon":0},{"id":"2505024274","title":"Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505024274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505024274?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:36","pubTimestamp":1737470191,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时36分,Akebia Therapeutics, Inc.股票出现异动,股价快速拉升5.07%。截至发稿,该股报2.18美元/股,成交量47.3209万股,换手率0.22%,振幅5.80%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.68%。其相关个股中,Inmed Pharmaceuticals Inc.、Evolus, Inc. Common Stock、Im Cannabis Corp.涨幅较大,Inmed Pharmaceuticals Inc.、大自然药业、Cbdmd, Inc.较为活跃,换手率分别为1859.59%、3.15%、2.61%,振幅较大的相关个股有Akanda Corp.、Flora Growth Corp.、Amneal Pharmaceuticals, Inc.,振幅分别为105.06%、104.15%、101.94%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223631986e33ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223631986e33ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AKBA"],"gpt_icon":0},{"id":"2504118780","title":"Akebia Therapeutics, Inc.盘中异动 大幅拉升5.44%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504118780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504118780?lang=zh_cn&edition=full","pubTime":"2025-01-18 02:10","pubTimestamp":1737137404,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日02时10分,Akebia Therapeutics, Inc.股票出现异动,股价快速上涨5.44%。截至发稿,该股报2.04美元/股,成交量428.997万股,换手率1.97%,振幅5.70%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体跌幅为1.49%。其相关个股中,Im Cannabis Corp.、Inmed Pharmaceuticals Inc.、和黄医药涨幅较大,Cbdmd, Inc.、大自然药业、Painreform Ltd.较为活跃,换手率分别为21.31%、14.10%、10.91%,振幅较大的相关个股有Cbdmd, Inc.、Alvotech C/Wts 、Aytu Biopharma, Inc.,振幅分别为21.41%、15.00%、12.44%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118021004a225ec1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118021004a225ec1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AKBA","BK4139"],"gpt_icon":0},{"id":"2503628678","title":"Akebia Therapeutics, Inc.盘中异动 早盘股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503628678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503628678?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:03","pubTimestamp":1736953420,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时03分,Akebia Therapeutics, Inc.股票出现异动,股价急速上涨5.25%。截至发稿,该股报1.99美元/股,成交量39.8299万股,换手率0.18%,振幅3.47%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.67%。其相关个股中,Therapeuticsmd, Inc.、Alvotech C/Wts 、博美集团涨幅较大,大自然药业、Cbdmd, Inc.、Intra-Cellular Therapies Inc.较为活跃,换手率分别为16.48%、6.00%、2.33%,振幅较大的相关个股有Talphera, Inc.、坎伯兰药业、苏轩堂,振幅分别为11.86%、10.49%、9.79%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152303409867444f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152303409867444f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AKBA","BK4139","LENZ"],"gpt_icon":0},{"id":"2503501704","title":"HC Wainwright & Co.:重申Akebia Therapeutics(AKBA.US)评级,由买入调整至买入评级, 目标价由7.50美元调整至7.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503501704","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503501704?lang=zh_cn&edition=full","pubTime":"2025-01-15 01:22","pubTimestamp":1736875351,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申Akebia Therapeutics(AKBA.US)评级,由买入调整至买入评级, 目标价由7.50美元调整至7.50美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/15012247459144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","AKBA"],"gpt_icon":0},{"id":"2503858503","title":"Akebia Therapeutics, Inc.盘中异动 急速上涨5.14%报1.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503858503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503858503?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:56","pubTimestamp":1736780184,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时56分,Akebia Therapeutics, Inc.股票出现异动,股价快速拉升5.14%。截至发稿,该股报1.84美元/股,成交量64.8217万股,换手率0.30%,振幅7.14%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体跌幅为1.03%。其相关个股中,Biofrontera Inc C/Wts 27/10/2026 、Intra-Cellular Therapies Inc.、脑再生科技涨幅较大,Intra-Cellular Therapies Inc.、大自然药业、Cbdmd, Inc.较为活跃,换手率分别为10.74%、7.82%、4.77%,振幅较大的相关个股有Citius Oncology, Inc.、正业生物、Biofrontera Inc.,振幅分别为17.39%、11.05%、9.82%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132256259864daa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132256259864daa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AKBA"],"gpt_icon":0},{"id":"2495030165","title":"Akebia Therapeutics, Inc.盘中异动 临近收盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495030165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495030165?lang=zh_cn&edition=full","pubTime":"2024-12-31 05:01","pubTimestamp":1735592463,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日05时01分,Akebia Therapeutics, Inc.股票出现异动,股价急速下挫5.13%。截至发稿,该股报1.85美元/股,成交量187.925万股,换手率0.86%,振幅4.62%。Akebia Therapeutics, Inc.股票所在的制药行业中,整体跌幅为0.92%。其相关个股中,Emergent Biosolutions Inc.、Biofrontera Inc C/Wts 27/10/2026 、Scilex Holding Company涨幅较大,大自然药业、Painreform Ltd.、苏轩堂较为活跃,换手率分别为37.39%、24.02%、14.37%,振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、Alvotech C/Wts 、Scilex Holding Company,振幅分别为40.56%、30.96%、23.10%。Akebia Therapeutics, Inc.公司简介:Akebia Therapeutics Inc是一家综合性生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231050103985570fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231050103985570fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AKBA","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akebia.com","stockEarnings":[{"period":"1week","weight":0.0282},{"period":"1month","weight":0.1016},{"period":"3month","weight":0.7588},{"period":"6month","weight":0.6849},{"period":"1year","weight":1.7466},{"period":"ytd","weight":1.1105}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0568},{"period":"3month","weight":0.1601},{"period":"6month","weight":0.0432},{"period":"1year","weight":0.1452},{"period":"ytd","weight":0.0821}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Akebia Therapeutics, Inc.依法于2007年2月27日在特拉华州成立。该公司是一家致力于:基于缺氧诱导因子的新型生物性专有疗法的研发,肾脏疾病患者所需产品商业化应用的生物制药公司。HIF是人体内红细胞生成和潜在贫血治疗新机制的主要调节器。Akebia的候选主导产品AKB-6548作为一种每日一次的口服产品,已经成功完成2a期概念验证。研究表明AKB-6548可以在不需要透析的情况下安全有效地提高继发性贫血和慢性肾病患者的血红蛋白水平。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.019017},{"month":2,"riseRate":0.454545,"avgChangeRate":0.061016},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.075459},{"month":4,"riseRate":0.5,"avgChangeRate":0.022435},{"month":5,"riseRate":0.583333,"avgChangeRate":0.042467},{"month":6,"riseRate":0.666667,"avgChangeRate":0.055123},{"month":7,"riseRate":0.5,"avgChangeRate":0.04864},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.024826},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.050514},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.111106},{"month":11,"riseRate":0.727273,"avgChangeRate":0.167816},{"month":12,"riseRate":0.454545,"avgChangeRate":0.084242}],"exchange":"NASDAQ","name":"Akebia Therapeutics, Inc.","nameEN":"Akebia Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Akebia Therapeutics, Inc.(AKBA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Akebia Therapeutics, Inc.,AKBA,Akebia Therapeutics, Inc.股票,Akebia Therapeutics, Inc.股票老虎,Akebia Therapeutics, Inc.股票老虎国际,Akebia Therapeutics, Inc.行情,Akebia Therapeutics, Inc.股票行情,Akebia Therapeutics, Inc.股价,Akebia Therapeutics, Inc.股市,Akebia Therapeutics, Inc.股票价格,Akebia Therapeutics, Inc.股票交易,Akebia Therapeutics, Inc.股票购买,Akebia Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Akebia Therapeutics, Inc.(AKBA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Akebia Therapeutics, Inc.(AKBA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}